ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT biotech, ISIN BE0974289218, on Euronext Brussels is suspended on the request of the company from 22/11/2019 at 09:00 CET until the publication of a press release. Source: […]
Compliance Day was held this week. The day was organized by the Compliance.be Forum. Compliance Day is an annual conference that focuses on current topics of importance to compliance officers in Belgium. In the course of the day, several representatives of the FSMA gave presentations to the more than 150 compliance officers in attendance. They […]
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT Biotech, ISIN BE0974289218 on Euronext Brussels will re-open on 15/11/2019 at 11:30 CET. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT Biotech, ISIN BE0974289218, on Euronext Brussels is suspended on the request of the company from 14/11/2019 at 10:10 CET until the publication of a press release concerning […]
The Financial Services and Markets Authority (FSMA) warns the public against the website named www.helvea-ltd.com, which offers saving plans and investment services without complying with Belgian financial legislation. The persons operating the website named www.helvea-ltd.com are not authorized to provide investment services in or from Belgium. Moreover, the offer made via that website shows numerous […]
This press release is not available in English, please consult the French or Dutch site. Source: FSMA